v3.21.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]    
Research and development (“R&D”) expenses, net $ 5,794 $ 3,529
Amortization of intangible assets 379 379
General and administrative expenses 2,497 2,058
Operating loss 8,670 5,966
Finance income, net (271) (65)
Loss before tax 8,399 5,901
Tax expenses 3
Net loss $ 8,402 $ 5,901
Basic and diluted loss per share of Common Stock (in Dollars per share) $ 0.35 $ 0.26
Weighted average number of shares of Common Stock outstanding, basic and diluted (in Shares) 23,944,573 22,897,723

Source